ProductsPricingFree Market DashboardMarket News FeedScannerChartsHeatmapMarket SectorsTrack RecordMAD AcademyMCP Connector

Madrigal Pharmaceuticals, Inc. (MDGL)

Nasdaq · Common stock · Pharmaceutical Preparations

$468.43+0.89 (+0.19%)

As of Oct 21, 2:16 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.

Follow MDGL in real time

Real-time quotes, Pro Charting, the scanner and the alert feed on MDGL and every other US listing.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Or open the free MDGL chart →

MDGL at a glance

Key statistics

$10.80B

Market capitalization

Previous close
$467.54
Open
$474.31
Day range
$467.68 – $482.88
Volume
179.2K
Average volume (30 sessions)
275.8K
Shares outstanding
23.10M
Earnings per share
$(14.07)
Price / book
20.6
Price / sales
8.4
Beta (1 year, vs SPY)
0.33

Where the price sits in its year

52-week range

34% of the range

Below the 52-week high
-23.8%
Above the 52-week low
+19.0%

Completed sessions through Oct 20, 2026

Technical snapshot

Below its 50-day and 200-day averages

20-day average
$485.11-3.6%
50-day average
$512.23-8.7%
200-day average
$503.80-7.2%
RSI (14)39.1

Between the conventional 30 and 70 bands.

+3.4%

1 week

-10.4%

1 month

-13.0%

3 months

-19.7%

Year to date

+6.5%

1 year

Price change over each window, from completed sessions. Past performance does not indicate future results.

Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.

The member platform, in real time

What members do with MDGL

Every plan

MDGL on Pro Charting

Every intraday interval in real time, the drawing kit and the full set of technical studies on MDGL.

See the plans →

Every plan

Screen names like MDGL

The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.

See the plans →

Analysis Tools Only

Set a price line on MDGL

Put MDGL on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.

See the plans →

Stock Alerts + Tools

Open alerts on MDGL

See whether there is an open premium alert on MDGL, with its entry, stop and exit, each one reviewed by an analyst before it is sent.

See the plans →

From the public news wire

MDGL headlines

Market news →

SEC Form 4, most recent first

Insider filings

How to read these →

  • Sibold William John

    −218

    President and CEO, Director · Open-market sale

    $116.84K · Sep 11, 2026

  • Sibold William John

    −640

    President and CEO, Director · Open-market sale

    $343.79K · Sep 9, 2026

  • Sibold William John

    −505

    President and CEO, Director · Open-market sale

    $272.80K · Sep 9, 2026

  • Sibold William John

    −368

    President and CEO, Director · Open-market sale

    $199.32K · Sep 11, 2026

  • Sibold William John

    −1.5K

    President and CEO, Director · Open-market sale

    $837.25K · Sep 11, 2026

  • Sibold William John

    −362

    President and CEO, Director · Open-market sale

    $196.08K · Sep 9, 2026

  • Sibold William John

    −1.0K

    President and CEO, Director · Open-market sale

    $557.56K · Sep 9, 2026

  • Sibold William John

    −215

    President and CEO, Director · Open-market sale

    $115.89K · Sep 9, 2026

About Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Exchange
Nasdaq
Security
Common stock
Industry
Pharmaceutical Preparations
Headquarters
West Conshohocken, PA
Employees
915
Listed since
Feb 6, 2007
Website
madrigalpharma.com
Educational content only. MadStockAlerts provides market commentary, research, and educational content. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security. Trading and investing involve substantial risk, including loss of capital. See the Risk Disclosure and Customer Agreement.

Pick the desk that fits how you trade

Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.